Get the Stockscreener App
313.01
0.34%
1.06
After Hours:
313.01
Insulet Corporation stock is traded at $313.01, with a volume of 543.82K.
It is up +0.34% in the last 24 hours and up +1.39% over the past month.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
See More
Previous Close:
$311.95
Open:
$310.81
24h Volume:
543.82K
Relative Volume:
0.89
Market Cap:
$22.03B
Revenue:
$2.36B
Net Income/Loss:
$236.10M
P/E Ratio:
95.26
EPS:
3.286
Net Cash Flow:
$382.50M
1W Performance:
-2.46%
1M Performance:
+1.39%
6M Performance:
+24.07%
1Y Performance:
+35.19%
1-Day Range:
$309.26
$316.67
1-Week Range:
$309.26
$326.81
52-Week Range:
$229.56
$353.50
Insulet Corporation Stock (PODD) Company Profile
Name
Insulet Corporation
Sector
Industry
Phone
978-600-7000
Address
100 NAGOG PARK, ACTON, MA
Compare PODD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PODD
Insulet Corporation
|
313.01 | 21.96B | 2.36B | 236.10M | 382.50M | 3.286 |
|
ABT
Abbott Laboratories
|
123.62 | 216.79B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.72 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.24 | 141.06B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.70 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.45 | 49.01B | 5.88B | 1.34B | 577.90M | 2.3455 |
Insulet Corporation Stock (PODD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-21-25 | Resumed | Stifel | Buy |
| Sep-08-25 | Resumed | Oppenheimer | Outperform |
| Jun-16-25 | Initiated | Truist | Buy |
| May-30-25 | Initiated | Goldman | Buy |
| May-13-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Apr-29-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Mar-06-25 | Initiated | RBC Capital Mkts | Outperform |
| Nov-06-24 | Initiated | Bernstein | Outperform |
| May-30-24 | Initiated | Redburn Atlantic | Buy |
| May-07-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-21-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-04-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-02-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-21-23 | Upgrade | Citigroup | Neutral → Buy |
| Aug-21-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-26-23 | Initiated | Wolfe Research | Peer Perform |
| Nov-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-11-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-03-22 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-31-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-01-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Mar-19-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Jul-28-20 | Initiated | Wells Fargo | Overweight |
| Apr-24-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-03-20 | Initiated | BofA/Merrill | Neutral |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Dec-10-19 | Initiated | CFRA | Sell |
| Oct-23-19 | Initiated | Stifel | Hold |
| Oct-18-19 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-14-19 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-04-19 | Downgrade | UBS | Buy → Neutral |
| Oct-03-19 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-06-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Jun-10-19 | Downgrade | Northland Capital | Outperform → Market Perform |
| May-06-19 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-20-18 | Initiated | Berenberg | Buy |
| Feb-22-18 | Reiterated | Barclays | Overweight |
| Jan-08-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-03-17 | Upgrade | Canaccord Genuity | Hold → Buy |
| Sep-15-17 | Initiated | Barclays | Overweight |
View All
Insulet Corporation Stock (PODD) Latest News
Why Insulet Corporation (GOV) stock stays resilientTrade Performance Summary & Weekly High Potential Alerts - newser.com
Why Insulet Corporation (GOV) stock could outperform next year2025 Earnings Impact & Daily Market Momentum Tracking - newser.com
What technical signals suggest for Insulet Corporation stockJuly 2025 Outlook & Stepwise Entry/Exit Trade Alerts - newser.com
Why Insulet Corporation (GOV) stock could break out in 2025July 2025 Breakouts & Verified High Yield Trade Plans - newser.com
Will Insulet Corporation stock deliver strong dividend growth2025 Pullback Review & AI Forecasted Entry/Exit Points - newser.com
Amalgamated Bank Purchases 890 Shares of Insulet Corporation $PODD - MarketBeat
Is Insulet Corporation stock a buy before product launchesMarket Risk Report & AI Powered Market Trend Analysis - newser.com
Bessemer Group Inc. Sells 4,287 Shares of Insulet Corporation $PODD - MarketBeat
Envestnet Asset Management Inc. Has $41.99 Million Stock Holdings in Insulet Corporation $PODD - MarketBeat
Is Insulet Corporation stock poised for growthTrade Risk Assessment & Long-Term Safe Return Strategies - newser.com
Will Insulet Corporation rebound enough to break evenWeekly Trade Summary & Community Consensus Trade Signals - newser.com
Sector ETF performance correlation with Insulet CorporationQuarterly Growth Report & High Accuracy Buy Signal Tips - newser.com
How institutional ownership impacts Insulet Corporation stockQuarterly Profit Summary & Weekly High Return Stock Forecasts - newser.com
Insulet Corporation $PODD Shares Sold by Jennison Associates LLC - MarketBeat
New York Life Investment Management LLC Sells 7,290 Shares of Insulet Corporation $PODD - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Purchases 1,300 Shares of Insulet Corporation $PODD - MarketBeat
Advanced analytics toolkit walkthrough for Insulet CorporationDay Trade & Verified Entry Point Detection - newser.com
Here's Why Insulet (PODD) is a Strong Growth Stock - sharewise.com
Can Insulet Corporation stock sustain revenue growthQuarterly Trade Report & Verified Momentum Stock Alerts - newser.com
Multi asset correlation models including Insulet Corporation2025 Historical Comparison & Weekly Watchlist for Hot Stocks - newser.com
How to interpret RSI for Insulet Corporation stockWeekly Trade Summary & Community Consensus Trade Signals - newser.com
Insulet Corporation (PODD) Stock Forecasts - Yahoo! Finance Canada
Insulet Corporation (PODD) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Insulet (PODD) to Release Earnings on Thursday - MarketBeat
Full technical analysis of Insulet Corporation stock2025 Bull vs Bear & Growth Focused Entry Point Reports - newser.com
Why Insulet Corporation stock is rated strong buyJuly 2025 PreEarnings & Intraday High Probability Setup Alerts - newser.com
Why Insulet Corporation stock appeals to dividend seekersJuly 2025 Update & Verified Momentum Stock Watchlist - newser.com
Will Insulet Corporation outperform the marketMarket Risk Analysis & High Accuracy Buy Signal Tips - newser.com
Why Insulet Corporation stock could outperform in 2025Rate Cut & Weekly Chart Analysis and Trade Guides - newser.com
How to monitor Insulet Corporation with trend dashboardsRate Cut & Low Risk Investment Opportunities - newser.com
Insulet Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Does Insulet (NASDAQ:PODD) Have A Healthy Balance Sheet? - 富途牛牛
Insulet (PODD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
RBC Capital Lifts Insulet (PODD) PT to $365 on Strong Momentum, Q3 Guidance Optimism - Insider Monkey
Insulet’s New Study on Simplified Onboarding for Type 2 Diabetes Management: A Potential Game Changer - MSN
Insulet’s Omnipod 5 SA2.0 Study: A Leap in Diabetes Management - MSN
Insulet’s Omnipod 5 Study: A Real-World Evaluation of Diabetes Management - MSN
Ownership Capital B.V. Sells 36,689 Shares of Insulet Corporation $PODD - MarketBeat
Whalen Wealth Management Inc. Sells 1,789 Shares of Insulet Corporation $PODD - MarketBeat
Insulet Corp. Experiences Evaluation Revision Amid Strong Market Performance and Technical Indicators - Markets Mojo
Insulet Corporation Stock (PODD) Financials Data
Revenue
Net Income
Cash Flow
EPS
14.63%
0.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):